Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Breast Cancer Clinical Advisory Board
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
      • Breast Cancer Clinical Advisory Board
    • COVID-19
      • Introduction
      • Science
      • Collaborators
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
  • Contact Us

News Releases

Investors

Investors

  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • All News
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

Anixa Biosciences Announces Completion of Pre-Sub Meeting with FDA for its Cchek™ Cancer Diagnostic Test

December 19, 2018

Anixa Biosciences Presents Positive Data on its Liquid Biopsy for Early Detection of Breast Cancer at AACR Conference

December 3, 2018

Anixa Biosciences To Present Cchek™ Breast Cancer Data at AACR Special Conference on Tumor Immunology and Immunotherapy

November 15, 2018

Anixa Biosciences Presents Positive Data from its Artificial Intelligence Powered Liquid Biopsy for Prostate Cancer at SITC Conference

November 12, 2018

Anixa Biosciences to Present at SITC Annual Meeting

October 29, 2018

Anixa Biosciences Announces Scheduling of Pre-Sub Meeting with FDA for its Cchek™ Cancer Diagnostic Test

October 24, 2018

Moffitt Cancer Center and Anixa Biosciences Announce Completion of Pre-IND Meeting with FDA for CAR-T Therapy

October 22, 2018

Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference

October 17, 2018

Anixa Biosciences Files Pre-Submission and Requests Meeting with FDA Regarding Cchek™ Artificial Intelligence based Cancer Detection Technology

October 15, 2018

Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board

October 11, 2018

RSS
  • 1
  • 2
  • 3
  • 4
  • Next »

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Mar 13, 2023

Anixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank

Read More...
Mar 2, 2023

Anixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders

Read More...
Feb 27, 2023

Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology

Read More...
Copyrights © 2023 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap